Interestingly, in addition to the expected circadian rhythm-specific pathways, we identified functions such as glucocorticoid receptor signalling and regulation of transcription of RNA polymerase II, which we and others have demonstrated to be implicated in SMA pathogenesis (Fig. 7C) (37,55). The gene discussed is NR3C1; the disease is proximal spinal muscular atrophy.